Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $260,924 - $513,074
4,100 Added 16.8%
28,500 $1.9 Million
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $657,865 - $1.08 Million
6,500 Added 36.31%
24,400 $2.9 Million
Q1 2024

May 01, 2024

SELL
$85.37 - $115.44 $2.72 Million - $3.68 Million
-31,900 Reduced 64.06%
17,900 $1.91 Million
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $2.54 Million - $3.81 Million
36,500 Added 274.44%
49,800 $4.95 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $327,794 - $430,474
3,400 Added 34.34%
13,300 $1.37 Million
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $272,550 - $369,219
2,300 Added 30.26%
9,900 $1.2 Million
Q1 2023

May 09, 2023

BUY
$135.66 - $197.02 $122,094 - $177,318
900 Added 13.43%
7,600 $1.17 Million
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $130,218 - $231,044
1,100 Added 19.64%
6,700 $1.2 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $35,421 - $58,254
300 Added 5.66%
5,600 $662,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $4.51 Million - $6.8 Million
-38,500 Reduced 87.9%
5,300 $757,000
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $3.28 Million - $6.09 Million
25,900 Added 144.69%
43,800 $7.55 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $858,116 - $1.4 Million
3,800 Added 26.95%
17,900 $4.55 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $3.13 Million - $6.83 Million
14,100 New
14,100 $5.43 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $1.14 Million - $1.93 Million
-10,400 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $289,256 - $747,384
-4,400 Reduced 29.73%
10,400 $1.09 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $804,232 - $1.4 Million
14,800 New
14,800 $1.05 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.